Clinical TrialID 2767

Single and Multiple Doses of an Oral Formulation of L-Homoarginine in Healthy Human Subjects

NCT02675660

Healthy

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
2767
Evidence Id
2767
Core Evidence Id
2767
Source Clinical Trial Id
2741
Herb2 Clinical Trial Id
HBCT002741
Nct Id
NCT02675660
Title
Single and Multiple Doses of an Oral Formulation of L-Homoarginine in Healthy Human Subjects
Status
Completed
Phase
Phase 1
Study Result
No
Study Condition
Healthy
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
Intervention
DIETARY_SUPPLEMENT: L-Homoarginine|DRUG: Placebo
Intervention Allocation
Randomized
Intervention Model
Crossover
Intervention Mask
Triple
Intervention Purpose
Basic_Science
Gender
All
Age
Adult, Older_Adult
Enrollment
20
Outcome Measure
Area under the plasma concentration versus time curve (AUC), To determine the AUC of L-homoarginine (a) following a single oral dose and (b) following administration of multiple oral doses of L-homoarginine., 1 Month
Sponsor Collaborator
Universitätsklinikum Hamburg-Eppendorf
Funded By
OTHER
Location
Other Id
Homoarginine-UKE-KP2012-01
Start Date
2014-04
Primary Completion Date
2015-04
Completion Date
2016-01
First Posted
2016-02-05
Results First Posted
Last Update Posted
2016-09-08
Study Document
Study Url
https://clinicaltrials.gov/study/NCT02675660
Title Cn
Title En
Single and Multiple Doses of an Oral Formulation of L-Homoarginine in Healthy Human Subjects
Bilingual Status
semi_complete